Australian Firm, Hopgood Ganim, Provides Advice Pro Bono To Assist COVID19 Vaccine Research

HopgoodGanim has advised Royal Brisbane and Women’s Hospital Foundation on a pro bono basis in a matter to fund COVID-19 vaccine research.

Firms: HopgoodGanim (Royal Brisbane and Women’s Hospital Foundation)

Deal: HopgoodGanim has advised the Royal Brisbane and Women’s Hospital Foundation (RBWHF) on a pro bono basis in relation to the receipt of a sizeable donation to fund their important COVID-19 vaccine research.

Value: Undisclosed.

Area: Property, tax, pro bono.

Key players: The transaction was led by property partner Tracey Rundle and tax partner Michael Patane. HopgoodGanim’s pro bono practice is led by corporate partner, Nicole Radice.

Deal significance: As reported last week across various media outlets, Queensland couple, Keith and Glenda Drake have agreed to donate the proceeds of their multimillion-dollar Sunshine Coast penthouse to the RBWHF Coronavirus Action Fund to support vital research into the development of a COVID-19 vaccine.

The money raised will go towards the expansion of national trials to test the effectiveness of two drugs in treating COVID-19, and to supporting other virus-related medical research.

RBWH Foundation CEO Simone Garske said the organisation was incredibly grateful for the Drakes’ generous sacrifice.